Dr Timothy Eyes BSc, MSc

Research interests

The Interplay Between Aggregation and Immunogenicity in Biopharmaceuticals.

Two key concerns over product quality within the biopharmaceutical industry are immunogenicity and aggregation of therapeutic proteins. We are developing a model system to understand the interplay of aggregation and immunogenicity to aid development of improved quality, safer and more effective therapies.
This is a BBSRC LINK project in collaboration with Lonza - Applied Protein Services (Cambridge, UK).